Nutex Health (NUTX) Convertible Debt (2013 - 2022)

Nutex Health has disclosed Convertible Debt across 8 years of filings, most recently posting $5400.0 for Q4 2022.

• Convertible Debt for Q4 2022 came in at $5400.0, down 99.91% year-over-year; the trailing twelve-month figure through Dec 2022 was $5400.0 (down 99.91% YoY), and the FY2022 annual result was $5400.0, down 99.91% from the prior year.
• Convertible Debt came in at $5400.0 for Q4 2022 at Nutex Health, down from $6.0 million in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $6.0 million in Q4 2021 to a low of $5400.0 in Q4 2022.
• The 5-year median for Convertible Debt is $409287.0 (2018), against an average of $1.1 million.
• Across the five-year window, Convertible Debt soared 13769.44% in 2018 and plunged 99.91% in 2022, its largest moves.
• Nutex Health's Convertible Debt stood at $299996.0 in 2018, then grew by 9.55% to $328652.0 in 2019, then dropped by 29.9% to $230399.0 in 2020, then soared by 2504.18% to $6.0 million in 2021, then slumped by 99.91% to $5400.0 in 2022.
• The last three Convertible Debt figures came in at $5400.0 (Q4 2022), $6.0 million (Q4 2021), and $230399.0 (Q1 2020), per Business Quant data.